We are live on
!
Find out more
Pictet Asset Management Portfolio holdings
AUM
$105B
1-Year Est. Return
38.07%
This Fund
S&P 500
This Quarter
Est. Return
-2.69%
1 Year Est. Return
+38.07%
3 Year Est. Return
+113.98%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$90B
AUM Growth
-$2.64B
(-2.9%)
Cap. Flow
+$2.07B
Cap. Flow
% of AUM
2.3%
Top 10 Holdings %
Top 10 Hldgs %
17.41%
Holding
2,101
New
60
Increased
1,058
Reduced
623
Closed
92
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Synopsys
SNPS
|
+$327M |
| 2 |
Broadcom
AVGO
|
+$315M |
| 3 |
Mastercard
MA
|
+$262M |
| 4 |
Intuit
INTU
|
+$226M |
| 5 |
Digital Realty Trust
DLR
|
+$149M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$187M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$169M |
| 3 |
WCN
Waste Connections
WCN
|
+$141M |
| 4 |
NextEra Energy
NEE
|
+$134M |
| 5 |
Cadence Design Systems
CDNS
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.36% |
| 2 | Industrials | 16.63% |
| 3 | Healthcare | 13.3% |
| 4 | Financials | 8.12% |
| 5 | Consumer Discretionary | 7.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
SL Green Realty
SLG
$4B
| $866K | ﹤0.01% |
15,007
-5,777
| -28% | -$364K |
|
1127
Glaukos
GKOS
$11B
| $865K | ﹤0.01% |
8,782
+1,200
| +16% | +$160K |
|
1128
Rocket Lab Corp
RKLB
$51.9B
| $864K | ﹤0.01% |
48,320
+5,486
| +13% | +$131K |
|
|
BCPC
1129
Balchem Corp
BCPC
$5.73B
| $861K | ﹤0.01% |
5,196
+94
| +2% | +$15.4K |
|
1130
Stride
LRN
$3.27B
| $860K | ﹤0.01% |
6,801
+1,708
| +34% | +$216K |
|
1131
FTI Consulting
FCN
$4.22B
| $857K | ﹤0.01% |
5,225
+356
| +7% | +$64K |
|
1132
Arrow Electronics
ARW
$10.7B
| $856K | ﹤0.01% |
8,247
+257
| +3% | +$28.3K |
|
1133
United Bankshares
UBSI
$6.66B
| $850K | ﹤0.01% |
24,558
-385
| -2% | -$14.1K |
|
1134
Champion Homes
SKY
$5.1B
| $847K | ﹤0.01% |
8,941
+288
| +3% | +$27.6K |
|
1135
ONE Gas
OGS
$5.05B
| $840K | ﹤0.01% |
11,117
+2,347
| +27% | +$169K |
|
1136
Landstar System
LSTR
$6.31B
| $835K | ﹤0.01% |
5,564
+172
| +3% | +$27.7K |
|
1137
Glacier Bancorp
GBCI
$6.4B
| $832K | ﹤0.01% |
18,839
-676
| -3% | -$32.6K |
|
1138
SPS Commerce
SPSC
$2.75B
| $828K | ﹤0.01% |
6,232
-31,343
| -83% | -$4.93M |
|
1139
Gentex
GNTX
$4.93B
| $828K | ﹤0.01% |
35,519
+1,444
| +4% | +$36.9K |
|
1140
Hims & Hers Health
HIMS
$6.99B
| $824K | ﹤0.01% |
27,878
+4,749
| +21% | +$176K |
|
1141
Knife River
KNF
$3.83B
| $821K | ﹤0.01% |
9,108
+840
| +10% | +$81.8K |
|
|
JBTM
1142
JBT Marel
JBTM
$6.15B
| $818K | ﹤0.01% |
6,698
+287
| +4% | +$36.3K |
|
1143
Saic
SAIC
$5.34B
| $818K | ﹤0.01% |
7,283
+254
| +4% | +$27.4K |
|
1144
Elanco Animal Health
ELAN
$11.1B
| $810K | ﹤0.01% |
77,103
+10,463
| +16% | +$118K |
|
1145
Radian Group
RDN
$4.87B
| $809K | ﹤0.01% |
24,480
+735
| +3% | +$23.9K |
|
1146
Cirrus Logic
CRUS
$6.11B
| $806K | ﹤0.01% |
8,090
+283
| +4% | +$29.2K |
|
|
TUYA
1147
Tuya Inc
TUYA
$1.1B
| $805K | ﹤0.01% |
265,719
-26,882
| -9% | -$79.5K |
|
1148
Shift4
FOUR
$3.47B
| $805K | ﹤0.01% |
9,834
+1,569
| +19% | +$162K |
|
1149
Plains GP Holdings
PAGP
$4.98B
| $804K | ﹤0.01% |
+37,572
| New | +$791K |
|
1150
GXO Logistics
GXO
$5.52B
| $803K | ﹤0.01% |
20,539
+266
| +1% | +$11.1K |
|
Similar funds
Pictet Asset Management's Q1 2025 Portfolio in Review
As of Q1 2025, Pictet Asset Management held 2,101 positions worth $90B, down 2.9% from $92.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Pictet Asset Management's Q1 2025 filing shows 60 new, 1,058 increased, 623 reduced and 92 closed positions. Its largest new stake was Verona Pharma: 703,063 shares worth $44.6M. The largest sale was Intra-Cellular Therapies Inc., an estimated $187M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Industrials and Healthcare.
- Pictet Asset Management's largest Q1 2025 buy was Verona Pharma: 703,063 shares worth $44.6M.
- Pictet Asset Management added most to Synopsys in Q1 2025, an estimated $327M increase.
- Pictet Asset Management's biggest Q1 2025 reduction was Intra-Cellular Therapies Inc., cutting an estimated $187M.
- Pictet Asset Management fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q1 2025, selling an estimated $46.5M.
- Pictet Asset Management's ten largest holdings make up 17% of its $90B portfolio in Q1 2025.
- Pictet Asset Management opened 60 new positions and closed 92 in Q1 2025.
- Pictet Asset Management's portfolio value fell 2.9% quarter-over-quarter to $90B.
Based on Pictet Asset Management's 13F filing for Q1 2025, filed 5 May 2025.